These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 4654639

  • 41. [Changes in fibrinolysis after administration of theophylline nicotinate].
    Locatelli R, Centonza D, Bregani P, Esposito R.
    Haematologica; 1967; 52(2):132-42. PubMed ID: 4976133
    [No Abstract] [Full Text] [Related]

  • 42. EFFECT OF LOW MOLECULAR WEIGHT DEXTRAN ON SURVIVAL FOLLOWING HEMORRHAGIC SHOCK.
    GREENFIELD L, BLALOCK A.
    Surgery; 1964 May; 55():684-6. PubMed ID: 14146528
    [No Abstract] [Full Text] [Related]

  • 43. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G, Vogel A.
    Dermatol Wochenschr; 1967 Nov 18; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [On the treatment of hyperlipemia with theophylline nicotinate].
    Ciammaichella A.
    Atti Soc Ital Cardiol; 1969 Jan 21; 2():251-60. PubMed ID: 5406537
    [No Abstract] [Full Text] [Related]

  • 47. [Evaluation of indications for clinical use of dextran in the light of experiences of the Institute of Hematology].
    Rudowski W.
    Pol Tyg Lek; 1969 Jul 07; 24(27):1044-7. PubMed ID: 5805882
    [No Abstract] [Full Text] [Related]

  • 48. Treatment of experimental haemorrhagic shock in dogs.
    Hollmén A, Karvonen S, Saukkonen J, Valanne J.
    Ann Chir Gynaecol Fenn; 1970 Jul 07; 59(3):119-26. PubMed ID: 5507359
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Hepato-portal hemodynamics in experimental hemorrhagic shock. 1. Variations induced by integrating the blood volume with blood, blood and Rinter-lactate, polyvinylpyrrolidone (PVP) and low molecular weight dextran (LMWD)].
    Foti F, Di Benedetto A, Russo S, Banna P, Bonfiglio S, Cirino E, Russo A.
    G Ital Chir; 1968 Sep 07; 24(5):753-69. PubMed ID: 5754804
    [No Abstract] [Full Text] [Related]

  • 51. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC, Fumagalli G, Locatelli R.
    Arch Patol Clin Med; 1965 Jun 07; 41(6):479-83. PubMed ID: 5319767
    [No Abstract] [Full Text] [Related]

  • 52. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M, Bockelmann R.
    Med Klin; 1966 Feb 04; 61(5):184-6. PubMed ID: 5982907
    [No Abstract] [Full Text] [Related]

  • 53. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R, Renda A.
    Minerva Cardioangiol; 1971 Dec 04; 19(12):709-18. PubMed ID: 5129037
    [No Abstract] [Full Text] [Related]

  • 54. [Effect of xanthinol nicotinate on the isolated perfused lungs].
    Husemann B.
    Arzneimittelforschung; 1970 Aug 04; 20(8):1070-1. PubMed ID: 5536505
    [No Abstract] [Full Text] [Related]

  • 55. [Influence of therapy and adjustment of diabetics with xanthine nicotinate].
    Hahn J, Kaffarnik H.
    Med Klin; 1969 May 30; 64(22):1042-5. PubMed ID: 5800195
    [No Abstract] [Full Text] [Related]

  • 56. EFFECT OF LOW MOLECULAR WEIGHT DEXTRANS AND FIBRINOLYSINS ON HEMORRHAGIC SHOCK.
    SCHLUETER TM, KELLY TR.
    Surg Forum; 1964 May 30; 15():32-4. PubMed ID: 14189393
    [No Abstract] [Full Text] [Related]

  • 57. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE, Konrad D, Sawade H, Kühl I.
    Med Klin; 1968 Nov 01; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract] [Full Text] [Related]

  • 58. [Effect of several dextran 40 and mannitol combination preparations on circulation, renal cortical bloodflow and renal function in hemorrhagic shock].
    Schindler E, May P, Lübke P, Dannemann HJ, Haubensak K, Bihler K.
    Urologe; 1971 Mar 01; 10(2):80-3. PubMed ID: 5577985
    [No Abstract] [Full Text] [Related]

  • 59. [Studies on the long-term treatment of experimental animals with plasma substitutes].
    Lutz H, Peter K.
    Bibl Haematol; 1971 Mar 01; 37():320-8. PubMed ID: 5138917
    [No Abstract] [Full Text] [Related]

  • 60. Effect of P286 on blood catecholamine levels and survival rate in dogs exposed to hemorrhagic shock.
    Osborne MW, Rowe H, Kaufman R, Johnson M.
    Arch Int Pharmacodyn Ther; 1968 Jul 01; 174(1):167-80. PubMed ID: 5684283
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.